Disseminated Penicillium marneffei infection in a renal-transplant recipient successfully treated with liposomal amphotericin B [5]

Transplantation

Volumn 76, Issue 7, 2003, Pages 1136-1137

  Wang, Jiun Ling ^a   Hung, Chien Ching ^a,b   Chang, Shan Chwen ^a   Chueh, Shih Chieh ^a   La, Ming Kuen ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE;

ADULT; CASE REPORT; CHRONIC GLOMERULONEPHRITIS; FUNGUS GROWTH; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; LETTER; MAINTENANCE THERAPY; MALE; MYCOSIS; NEPHROTOXICITY; PENICILLIUM MARNEFFEI; PRIORITY JOURNAL; RECIPIENT; SIDE EFFECT;

AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; PENICILLIUM;

EID: 0142040131     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000088667.02294.E7     Document Type: Letter

References (5)

1. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997; 10: 86.
2. Supparatpinyo K, Khamwan C, Baosoung V, et al. Disseminated Penicillium marneffei infection in Southeast Asia. Lancet 1994; 344: 110.
3. Hsueh PR, Teng LJ, Hung CC, et al. Molecular evidence for strain dissemination of Penicillium marneffei: an emerging pathogen in Taiwan. J Infect Dis 2000; 181: 1706.
4. Supparatpinyo K, Perriens J, Nelson KE, et al. A controlled trial of itraconazole to prevent relapse of Penicillium marneffei infection in patients infected with the human immunodeficiency virus. N Engl J Med 1998; 339: 1739.
5. Harbarth S, Pestotnik SL, Lloyd JF, et al. The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy. Am J Med 2001; 11: 528.